Why This Vaccine Pioneer is Turning Heads on Wall Street
Valneva SE, a specialised vaccine manufacturer, is noted for its innovative biological solutions tackling unmet medical needs. The stock price recently fell to £7.17, promising potential for adventurous investors with…